...
首页> 外文期刊>Letters in drug design & discovery >Design, Synthesis and in silico Studies of New 5-substituted-2-(2-(5-aryl-1H-1,2,4-triazole-3-ylthio) acetyl) Hydrazine Carbothioamide/Carboxamides for Anticonvulsant Activity
【24h】

Design, Synthesis and in silico Studies of New 5-substituted-2-(2-(5-aryl-1H-1,2,4-triazole-3-ylthio) acetyl) Hydrazine Carbothioamide/Carboxamides for Anticonvulsant Activity

机译:新的5取代-2-(2-(5-芳基-1H-1,2,4-三唑-3-基硫基)乙酰基)酰胺碳甲酰胺/甲酰胺用于抗惊厥活性的设计,合成及二氧化硅研究

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Research on the synthesis of anticonvulsants is still in progress as they produce adverse effects with lesser activity as well as the patients become resistant to drug therapy. 1,2,4-triazole scaffold is a resource for the synthesis of anticonvulsant agents having better pharmacological action. Virtual Screening plays an important role to achieve binding affinity, receptor and library pre-processing, docking, scoring and top scoring hits. Optimization of drug ADME parameters continues to play an important role to achieve proof of concept, and ultimately efficacy, safely in clinical trials to address unmet medical need.
机译:背景:对抗惊厥药的合成的研究仍在进行,因为它们产生较小的活动以及患者对药物治疗造成的不良反应。 1,2,4-三唑支架是合成具有更好药理学作用的抗惊厥药的资源。 虚拟筛选在实现结合亲和力,受体和图书馆预处理,对接,评分和最高评分命中的重要作用。 药物Adme参数的优化继续发挥重要作用,以实现概念证明,最终有效,安全地在临床试验中解决未满足的医疗需求。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号